S&P 500

5.868,55

-0,22%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
89bio Inc (ETNB)
89bio Inc (ETNB) Notícias

ETNB

89bio (ETNB)

89bio Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ETNB

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
23/12/2024	18:41	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ETNB	89bio Inc
16/12/2024	08:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ETNB	89bio Inc
16/12/2024	08:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETNB	89bio Inc
13/11/2024	19:31	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ETNB	89bio Inc
08/11/2024	16:17	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ETNB	89bio Inc
07/11/2024	18:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ETNB	89bio Inc
30/10/2024	17:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ETNB	89bio Inc
30/10/2024	17:01	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ETNB	89bio Inc
01/03/2024	19:06	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:ETNB	89bio Inc
01/03/2024	19:03	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ETNB	89bio Inc
14/02/2024	13:32	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ETNB	89bio Inc
21/09/2023	10:07	Dow Jones News	89bio Gets FDA Breakthrough Designation for Pegozafermin in NASH	NASDAQ:ETNB	89bio Inc
09/06/2023	17:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ETNB	89bio Inc
07/06/2023	18:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ETNB	89bio Inc
05/06/2023	18:35	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:ETNB	89bio Inc
25/04/2023	18:29	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NASDAQ:ETNB	89bio Inc
24/04/2023	17:36	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:ETNB	89bio Inc
24/04/2023	17:34	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ETNB	89bio Inc
24/03/2023	08:00	GlobeNewswire Inc.	89bio, Inc. Announces Upsized Pricing of $275 Million Public Offering of Common Stock	NASDAQ:ETNB	89bio Inc
22/03/2023	18:06	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ETNB	89bio Inc
22/03/2023	17:16	GlobeNewswire Inc.	89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:ETNB	89bio Inc
15/03/2023	08:06	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ETNB	89bio Inc
15/03/2023	07:25	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ETNB	89bio Inc
14/02/2023	19:25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ETNB	89bio Inc
14/02/2023	19:17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ETNB	89bio Inc
14/02/2023	18:33	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ETNB	89bio Inc
10/02/2023	18:04	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	NASDAQ:ETNB	89bio Inc
31/01/2023	08:08	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ETNB	89bio Inc
04/01/2023	18:01	GlobeNewswire Inc.	89bio Provides Business Update and Outlook for 2023	NASDAQ:ETNB	89bio Inc
12/12/2022	20:30	GlobeNewswire Inc.	89bio Announces Publication of Results of Phase 1b/2a Study of Pegozafermin for the Treatment of NASH in The Lancet Gastroenterology & Hepatology	NASDAQ:ETNB	89bio Inc